Epidemic status,clinical characteristics,prevention and therapy of respiratory syncytial virus infection in children after the lifting of non-pharmaceutical interventions
Non-pharmaceutical interventions(NPIs)against the COVID-19 restricted the spread of respiratory infectious diseases.After the lifting of NPIs for the COVID-19 pandemic,a resurgence of respiratory syncytial virus(RSV)has been observed in multiple countries and regions globally,exhibiting epidemiological and clinical characteristics distinct from previous RSV epidemic during the pre-COVID-19 era.This resurgence poses new challenges for clinical management of RSV infection.This review elucidates the changes in epidemiological and clinical features of pediatric RSV epidemic after the lifting of NPIs,potential mechanisms underlying these changes,as well as advances in RSV prevention and control,aiming to enhance the understanding of pediatric RSV infection following the lifting of NPIs,and provides reference for further optimization of strategies in the prevention,control,and clinical management of pediatric RSV infection.
NETL
NSTL
万方数据
